Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial E. Grünig (Heidelberg, Germany), A. Mackenzie (Glasgow, United Kingdom), A. Peackock (Glasgow, United Kingdom), C. Eichstaedt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), R. Nechwatal (Heidelberg, Germany), S. Ulrich (Zurich, Switzerland), S. Saxer (Zurich, Switzerland), M. Bussotti (Milan, Italy), M. Sommaruga (Milan, Italy), S. Ghio (Pavia, Italy), L. Gumbiene (Vilnius, Lithuania), E. Paleviciute (Vilnius, Lithuania), E. Jureviciene (Vilnius, Lithuania), A. Cittadini (Salerno, Italy), A. Stanziola (Naples, Italy), A. Marra (Naples, Italy), G. Kovacs (Graz, Austria), H. Olschewski (Graz, Austria), J. Barberà (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. Spruit (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), A. Vonk Noordegraaf (Amsterdam, Netherlands), A. Reis (Porto, Portugal), M. Santos (Porto, Portugal), S. Goncalves Viamonte (Porto, Portugal), H. Demeyer (Leuven, Belgium), M. Delcroix (Leuven, Belgium), E. Bossone (Naples, Italy), M. Johnson (Glasgow, United Kingdom)
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Grünig (Heidelberg, Germany), A. Mackenzie (Glasgow, United Kingdom), A. Peackock (Glasgow, United Kingdom), C. Eichstaedt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), R. Nechwatal (Heidelberg, Germany), S. Ulrich (Zurich, Switzerland), S. Saxer (Zurich, Switzerland), M. Bussotti (Milan, Italy), M. Sommaruga (Milan, Italy), S. Ghio (Pavia, Italy), L. Gumbiene (Vilnius, Lithuania), E. Paleviciute (Vilnius, Lithuania), E. Jureviciene (Vilnius, Lithuania), A. Cittadini (Salerno, Italy), A. Stanziola (Naples, Italy), A. Marra (Naples, Italy), G. Kovacs (Graz, Austria), H. Olschewski (Graz, Austria), J. Barberà (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. Spruit (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), A. Vonk Noordegraaf (Amsterdam, Netherlands), A. Reis (Porto, Portugal), M. Santos (Porto, Portugal), S. Goncalves Viamonte (Porto, Portugal), H. Demeyer (Leuven, Belgium), M. Delcroix (Leuven, Belgium), E. Bossone (Naples, Italy), M. Johnson (Glasgow, United Kingdom). Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial. 3972
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Do we need controlled clinical trials in pulmonary arterial hypertension? Source: Eur Respir J 2001; 17: 1-3 Year: 2001
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2016
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Source: Eur Respir J 2009; 34: 231-242 Year: 2009
Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial Source: Eur Respir J 2010; 35: 571-577 Year: 2010
Multicentre trials on specialised exercise training and rehabilitation are useful in patients with pulmonary hypertension Source: Eur Respir J, 54 (5) 1901631; 10.1183/13993003.01631-2019 Year: 2019
Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017
Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study) Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017
Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN) Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013
Non-invasive positive pressure ventilation (NIPPV)for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 403s Year: 2003
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019
Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial Source: International Congress 2017 – Techniques to treat asthma Year: 2017
Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009
Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019 Year: 2020
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019
Effectiveness of a home-based pulmonary rehabilitation program compared to a hospital-based pulmonary rehabiltation program in COPD patients. A Spanish multicenter randomized trial Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation Year: 2006
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021